AstraZeneca
AZN
#47
Rank
A$420.95 B
Marketcap
A$135.77
Share price
0.17%
Change (1 day)
32.44%
Change (1 year)

AstraZeneca (AZN) - Total debt

Total debt on the balance sheet as of September 2025 : A$49.12 Billion

According to AstraZeneca's latest financial reports the company's total debt is A$49.12 Billion. A companyโ€™s total debt is the sum of all current and non-current debts.

AstraZeneca - Total debt on balance sheet (from 1996 to 2025)

Total debt by year

Year Total debt Change
2024-12-31A$48.41 B16.12%
2023-12-31A$41.69 B-2.64%
2022-12-31A$42.82 B1.17%
2021-12-31A$42.32 B59.71%
2020-12-31A$26.50 B1.81%
2019-12-31A$26.03 B-4.05%
2018-12-31A$27.13 B18.95%
2017-12-31A$22.80 B-2.18%
2016-12-31A$23.31 B12.85%
2015-12-31A$20.66 B55.96%
2014-12-31A$13.24 B13.9%
2013-12-31A$11.63 B17.25%
2012-12-31A$9.92 B9.05%
2011-12-31A$9.09 B0.21%
2010-12-31A$9.07 B-26.28%
2009-12-31A$12.31 B660.83%
2008-12-31A$1.61 B-90.66%
2007-12-31A$17.33 B1017.38%
2006-12-31A$1.55 B-5.48%
2005-12-31A$1.64 B0.09%
2004-12-31A$1.63 B167.89%
2003-12-31A$0.61 B-59.14%
2002-12-31A$1.49 B-20.03%
2001-12-31A$1.87 B23.89%
2000-12-31A$1.51 B-11.21%
1999-12-31A$1.70 B-8.38%
1998-12-31A$1.85 B3.31%
1997-12-31A$1.79 B14.95%
1996-12-31A$1.56 B

Total debt for similar companies or competitors

Company Total debt/th> differencediff. Country
Bristol-Myers Squibb
BMY
A$76.84 B 56.41%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
A$91.60 B 86.47%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
A$62.28 B 26.79%๐Ÿ‡บ๐Ÿ‡ธ USA
GlaxoSmithKline
GSK
A$35.92 B-26.88%๐Ÿ‡ฌ๐Ÿ‡ง UK
Sanofi
SNY
A$38.43 B-21.76%๐Ÿ‡ซ๐Ÿ‡ท France
Eli Lilly
LLY
A$63.99 B 30.26%๐Ÿ‡บ๐Ÿ‡ธ USA
Johnson & Johnson
JNJ
A$68.94 B 40.34%๐Ÿ‡บ๐Ÿ‡ธ USA
Abbott Laboratories
ABT
A$19.48 B-60.34%๐Ÿ‡บ๐Ÿ‡ธ USA
Biogen
BIIB
A$9.92 B-79.80%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
A$48.20 B-1.87%๐Ÿ‡จ๐Ÿ‡ญ Switzerland